首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Gastric cancer

缩写:GASTRIC CANCER

ISSN:1436-3291

e-ISSN:1436-3305

IF/分区:6.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1926条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Wanrong Liu,Hui Tang,Ningning Li et al. Wanrong Liu et al.
Background: Immune checkpoint inhibitors (ICIs) improve survival in advanced gastric cancer (GC), yet predicting therapeutic benefit versus toxicity remains challenging. Elevated interleukin-6 (IL-6) is linked to poor pro...
Chishou Mitsuura,Satoshi Ida,Hiroki Tsubakihara et al. Chishou Mitsuura et al.
Background: Surgical complications after gastrectomy significantly impact recovery and long-term prognosis. While iron status influences outcomes, the conventional 20% transferrin saturation (TSAT) threshold ignores sex-s...
Qi Wang,Hongxue Meng,Shizheng Xiong et al. Qi Wang et al.
Background: Perineural invasion (PNI) is an established adverse prognostic factor in gastric cancer, but whether its prognostic effect varies with nodal burden and first metastatic site remains unclear. ...
Martin Korpan,Daniel Nothdurfter,Bernhard Doleschal et al. Martin Korpan et al.
Background: Mismatch-repair deficient (dMMR)/microsatellite instability-high (MSI-H) gastroesophageal adenocarcinoma (GEA) is associated with favorable prognosis but limited benefit from perioperative chemotherapy. Althou...
Alessandra Capuano,Maddalena Vescovo,Samanta Muzzin et al. Alessandra Capuano et al.
Background: EMILIN-1 is an extracellular matrix glycoprotein with tumor-suppressive functions. While its loss is implicated in cancer progression, its specific role in the gastric tumor microenvironment and its clinical r...
Yusuke Fujii,Shigeo Hisamori,Nobuaki Hoshino et al. Yusuke Fujii et al.
Background: The standard treatment for stage IV gastric cancer (GC) is chemotherapy, but advances in systemic therapy have rendered curative surgery a viable option. However, the role of minimally invasive surgery (MIS) i...
Komei Kuge,Junko Mukoyama,Yoshimi Yasukawa et al. Komei Kuge et al.
Background: Serum trefoil factor 3 (TFF3) has emerged as a promising biomarker for gastric cancer; however, its biological origin remains unclear. Methods...